Company / Operating Cash Flow per Share
Structure Therapeutics Inc. Operating Cash Flow per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.25
FY2025
5-year range
-$4.81 / -$0.72
FY2022-FY2025
Trend
-69.4%
vs FY2024
Sector context
#124 of 212
Health Care
What the data says
At $-1.25, Structure Therapeutics Inc.'s operating cash flow per share ranks #124 of 212 in the Health Care sector. Declined from $-0.72 to $-1.25 over the past 2 years.
Based on SEC 10-K filings.
-1.25 in FY2025.
Declined from $-0.72 to $-1.25 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#124 of 212 in Health CareTop 58% of 212This company -$1.25 Sector average -$14.72
▼
+91.5% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 69.4% year-over-year.
- Ranks #124 out of 212 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 9.77 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.25 | -69.4% |
| FY2024 | -$0.74 | -2.4% |
| FY2023 | -$0.72 | +85.0% |
| FY2022 | -$4.81 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026